Xencor Inc (XNCR) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Xencor Inc · Health Care · ref. ETF XLV · 53 calls · price $23.52
What the company does: Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.
📈 Xencor Inc (XNCR) stock price
$23.52+89.2% over range
Oct 14, 25low $10.41 · high $29.3Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
75% recommend buying · 8 analysts
📊 JPI status :
Xencor Inc is part of our 2026 selection (JPI Fair + JPI Risk +), bought at the start of the year and tracked live. It no longer shows in today's ranking: its target has been reached, there is no gap left. See the 2026 selection and its performance →
🎯 XNCR price target & analyst consensus — price $23.52
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$46+95.6%
Median target · of 8 targets$29.5+25.4%
Lowest target · 1 firm of 8$20-15.0%
Current price$23.52
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
675%
$26 ↔ $46
Below
225%
$20 ↔ $21
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 8 ratings (last 6 months)
Strong Buy113%
Buy563%
Hold225%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 XNCR price target all
All 53 calls, one by one, with our verdict on each firm.
→ See all 53 targets, analyst by analyst💡 The best analysts on XNCR most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in XNCR? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Xencor Inc? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on XNCR
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Leerink Swann | 100% | +97.5% | 2 |
| Guggenheim ↗ | 67% | +29.7% | 3 |
| Piper Sandler ↗ | 67% | -4.6% | 3 |
| Wedbush ↗ | 50% | +42.4% | 8 |
| SVB Leerink | 50% | -0.3% | 4 |
| HC Wainwright & Co. ↗ | 50% | -11.3% | 2 |
| Canaccord Genuity ↗ | 40% | +5.9% | 5 |
| Wells Fargo ↗ | 33% | +51.1% | 3 |
| RBC Capital ↗ | 33% | +8.7% | 9 |
| Mizuho ↗ | 33% | -18.3% | 3 |
📊 What $1,000 invested in Xencor Inc would be worth › open the full page
In short — $1,000 invested in Xencor Inc 10 years ago would be worth $1,023 today, i.e. +0%/yr on average. Best year: 2016 (+80%), worst: 2022 (-35%). Price performance, excluding dividends.
If I'd invested $1,000 in Xencor Inc
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $651 | -35% |
| 3 years ago | $574 | -43% |
| 5 years ago | $343 | -66% |
Return by year (Xencor Inc)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -2% | $976 (-2%) |
| 2025 | -33% | $651 (-35%) |
| 2024 | +8% | $704 (-30%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Xencor Inc
Loading news…
📋 All analyst calls on XNCR
Filtered on — · ✕ show all
Truist Securities ↗
Sep 28, 26
▲ Buy · 🎯$29
Price at call : $25 — upside +16%
Today : $23.52 — upside +23%
🎯 on XNCR : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Sep 28, 27
matures : Sep 28, 27
B of A Securities ↗
Sep 21, 26
■ Neutral neutral · not a buy · 🎯$26
Price at call : $25.16 — gap to target +3%
Today : $23.52 — gap to target +11%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 51.9% · +3.9% (156 calls)
in progress (365j)
matures : Sep 21, 27
matures : Sep 21, 27
▲ Overweight · 🎯$35
Price at call : $24.53 — upside +43%
Today : $23.52 — upside +49%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Sep 11, 27
matures : Sep 11, 27
■ Neutral neutral · not a buy · 🎯$21
Price at call : $26.61 — gap to target -21%
Today : $23.52 — gap to target -11%
🎯 on XNCR : 0% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Sep 3, 27
matures : Sep 3, 27
Raymond James ↗
Sep 1, 26
▲ Strong Buy · 🎯$46
Price at call : $26.9 — upside +71%
Today : $23.52 — upside +96%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 39.7% · -2.1% (219 calls)
in progress (365j)
matures : Sep 1, 27
matures : Sep 1, 27
RBC Capital ↗
Aug 6, 26
▲ Outperform · 🎯$20
Price at call : $20.81 — upside -4%
Today : $23.52 — upside -15%
🎯 on XNCR : 33% (6 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Outperform · 🎯$30
Price at call : $20.81 — upside +44%
Today : $23.52 — upside +28%
🎯 on XNCR : 50% (8 calls matureds) · 📊 on Health : 37% · +6.7% (54 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
Cantor Fitzgerald ↗
Aug 6, 26
▲ Overweight · 🎯$44
Price at call : $20 — upside +120%
Today : $23.52 — upside +87%
🎯 on XNCR : no call matured yet · 📊 on Health : 50% · +13.4% (168 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
See the other 45 calls, newest to oldest
▲ Outperform · 🎯$26
Price at call : $20.21 — upside +29%
Today : $23.52 — upside +11%
🎯 on XNCR : 50% (8 calls matureds) · 📊 on Health : 37% · +6.7% (54 calls)
in progress (365j)
matures : Jul 30, 27
matures : Jul 30, 27
Truist Securities ↗
Jul 7, 26
▲ Buy · 🎯$27
Price at call : $15.67 — upside +72%
Today : $23.52 — upside +15%
🎯 on XNCR : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
■ Neutral neutral · not a buy · 🎯$14
Price at call : $12.44 — gap to target +13%
Today : $23.52 — gap to target -40%
🎯 on XNCR : 0% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
■ Neutral neutral · not a buy · 🎯$13
Price at call : $11.89 — gap to target +9%
Today : $23.52 — gap to target -45%
🎯 on XNCR : 0% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Mar 24, 27
matures : Mar 24, 27
▲ Overweight · 🎯$27
Price at call : $12.77 — upside +111%
Today : $23.52 — upside +15%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
▲ Overweight · 🎯$26
Price at call : $15.69 — upside +66%
Today : $23.52 — upside +11%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
Truist Securities ↗
Nov 24, 25
▲ Buy · 🎯$29
Price at call : $17.26 — upside +68%
Today : $23.52 — upside +23%
🎯 on XNCR : no call matured yet · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Nov 24, 26
matures : Nov 24, 26
▲ Overweight · 🎯$18
Price at call : $13.9 — upside +29%
Today : $23.52 — upside -23%
🎯 on XNCR : 0% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
RBC Capital ↗
Nov 6, 25
▲ Outperform · 🎯$19
Price at call : $13.9 — upside +37%
Today : $23.52 — upside -19%
🎯 on XNCR : 33% (6 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Cantor Fitzgerald ↗
Nov 6, 25
▲ Overweight · 🎯$42
Price at call : $13.9 — upside +202%
Today : $23.52 — upside +79%
🎯 on XNCR : no call matured yet · 📊 on Health : 50% · +13.4% (168 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Overweight · 🎯$23
Price at call : $14.67 — upside +57%
Today : $23.52 — upside -2%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
RBC Capital ↗
Oct 27, 25
▲ Outperform · 🎯$18
Price at call : $14.25 — upside +26%
Today : $23.52 — upside -23%
🎯 on XNCR : 33% (6 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
B of A Securities ↗
Sep 3, 25
■ Neutral neutral · not a buy · 🎯$12
Price at call : $8.37 — gap to target +43%
Today : $23.52 — gap to target -49%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 51.9% · +3.9% (156 calls)
in progress (365j)
matures : Sep 3, 26
matures : Sep 3, 26
▲ Outperform · 🎯$26
Price at call : $8.33 — upside +212%
Today : $23.52 — upside +11%
Expected +212% · Actual +220% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 50% (8 calls matureds) · 📊 on Health : 37% · +6.7% (54 calls)
+219.6%
stock +220% · XLV +27%
matured Sep 2, 26
RBC Capital ↗
Aug 21, 25
▲ Outperform · 🎯$15
Price at call : $8.41 — upside +78%
Today : $23.52 — upside -36%
Expected +78% · Actual +245% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 33% (6 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
+244.8%
stock +245% · XLV +26%
matured Aug 21, 26
Wells Fargo ↗
Aug 7, 25
▲ Overweight · 🎯$27
Price at call : $7.23 — upside +273%
Today : $23.52 — upside +15%
Expected +273% · Actual +198% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 33% (3 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
+198.5%
stock +198% · XLV +29%
matured Aug 7, 26
▲ Outperform · 🎯$26
Price at call : $7.32 — upside +255%
Today : $23.52 — upside +11%
Expected +255% · Actual +184% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 50% (8 calls matureds) · 📊 on Health : 37% · +6.7% (54 calls)
+184.3%
stock +184% · XLV +28%
matured Aug 7, 26
▼ Underweight · 🎯$6
Price at call : $8.33 — upside -28%
Today : $23.52 — upside -74%
Expected -28% · Actual +54% · Reason (≤ −15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 37% · -8.6% (154 calls)
-53.5%
stock +54% · XLV +8%
matured May 8, 26
William Blair ↗
Apr 21, 25
▲ Outperform
Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 100% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)
+20.7%
stock +21% · XLV +8%
matured Apr 21, 26
Wells Fargo ↗
Feb 28, 25
▲ Overweight · 🎯$33
Price at call : $14.46 — upside +128%
Today : $23.52 — upside +40%
Expected +128% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 33% (3 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-14.9%
stock -15% · XLV +6%
matured Feb 28, 26
Wells Fargo ↗
Dec 12, 24
▲ Overweight · 🎯$37
Price at call : $24.03 — upside +54%
Today : $23.52 — upside +57%
Expected +54% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 33% (3 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-30.1%
stock -30% · XLV +11%
matured Dec 12, 25
Piper Sandler ↗
Dec 2, 24
▲ Overweight · 🎯$30
Price at call : $26.84 — upside +12%
Today : $23.52 — upside +28%
Expected +12% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 45.4% · +6.7% (251 calls)
-40.4%
stock -40% · XLV +5%
matured Dec 2, 25
BMO Capital ↗
Nov 8, 24
▲ Outperform · 🎯$34
Price at call : $23.31 — upside +46%
Today : $23.52 — upside +45%
Expected +46% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (4 calls matureds) · 📊 on Health : 43.3% · -2.2% (67 calls)
-41.1%
stock -41% · XLV -1%
matured Nov 8, 25
▲ Overweight · 🎯$28
Price at call : $23.62 — upside +19%
Today : $23.52 — upside +19%
Expected +19% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
-41.8%
stock -42% · XLV -2%
matured Nov 7, 25
RBC Capital ↗
Sep 26, 24
▲ Outperform · 🎯$34
Price at call : $20.25 — upside +68%
Today : $23.52 — upside +45%
Expected +68% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 33% (6 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-43.0%
stock -43% · XLV -11%
matured Sep 26, 25
BMO Capital ↗
Aug 6, 24
▲ Outperform · 🎯$32
Price at call : $15.7 — upside +104%
Today : $23.52 — upside +36%
Expected +104% · Actual -53% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (4 calls matureds) · 📊 on Health : 43.3% · -2.2% (67 calls)
-53.4%
stock -53% · XLV -12%
matured Aug 6, 25
RBC Capital ↗
Aug 6, 24
▲ Outperform · 🎯$31
Price at call : $17.85 — upside +74%
Today : $23.52 — upside +32%
Expected +74% · Actual -58% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 33% (6 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-58.0%
stock -58% · XLV -12%
matured Aug 6, 25
▲ Overweight · 🎯$27
Price at call : $19.9 — upside +36%
Today : $23.52 — upside +15%
Expected +36% · Actual -60% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (2 calls matureds) · 📊 on Health : 49% · +6.7% (149 calls)
-59.9%
stock -60% · XLV -13%
matured Jul 31, 25
Raymond James ↗
Jun 14, 24
▲ Strong Buy · 🎯$40
Price at call : $19.52 — upside +105%
Today : $23.52 — upside +70%
Expected +105% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 39.7% · -2.1% (219 calls)
-53.6%
stock -54% · XLV -7%
matured Jun 14, 25
BMO Capital ↗
Jun 14, 24
▲ Outperform · 🎯$32
Price at call : $19.52 — upside +64%
Today : $23.52 — upside +36%
Expected +64% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (4 calls matureds) · 📊 on Health : 43.3% · -2.2% (67 calls)
-53.6%
stock -54% · XLV -7%
matured Jun 14, 25
RBC Capital ↗
Jun 14, 24
▲ Outperform · 🎯$31
Price at call : $19.52 — upside +59%
Today : $23.52 — upside +32%
Expected +59% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 33% (6 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-53.6%
stock -54% · XLV -7%
matured Jun 14, 25
▲ Outperform · 🎯$36
Price at call : $21.34 — upside +69%
Today : $23.52 — upside +53%
Expected +69% · Actual -59% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 50% (8 calls matureds) · 📊 on Health : 37% · +6.7% (54 calls)
-58.9%
stock -59% · XLV -5%
matured May 10, 25
▲ Buy · 🎯$38
Price at call : $19.07 — upside +99%
Today : $23.52 — upside +62%
Expected +99% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 47.1% · +20.0% (68 calls)
-49.1%
stock -49% · XLV -2%
matured Apr 16, 25
Piper Sandler ↗
Feb 28, 24
■ Neutral neutral · not a buy · 🎯$24
Price at call : $22.95 — gap to target +5%
Today : $23.52 — gap to target +2%
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Feb 27, 25
matures : Feb 27, 25
RBC Capital ↗
Feb 28, 24
▲ Outperform · 🎯$32
Price at call : $22.95 — upside +39%
Today : $23.52 — upside +36%
Expected +39% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 33% (6 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
-33.1%
stock -33% · XLV +3%
matured Feb 27, 25
BMO Capital ↗
Feb 28, 24
▲ Outperform · 🎯$34
Price at call : $22.79 — upside +49%
Today : $23.52 — upside +45%
Expected +49% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (4 calls matureds) · 📊 on Health : 43.3% · -2.2% (67 calls)
-34.3%
stock -34% · XLV +1%
matured Feb 27, 25
▲ Outperform · 🎯$34
Price at call : $22.79 — upside +49%
Today : $23.52 — upside +45%
Expected +49% · Actual -34% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 50% (8 calls matureds) · 📊 on Health : 37% · +6.7% (54 calls)
-34.3%
stock -34% · XLV +1%
matured Feb 27, 25
▲ Buy · 🎯$50
Price at call : $20.02 — upside +150%
Today : $23.52 — upside +113%
Expected +150% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 100% (1 call matured) · 📊 on Health : 27.3% · -9.0% (88 calls)
+2.1%
stock +2% · XLV +2%
matured Jan 21, 25
Guggenheim ↗
Nov 8, 23
▲ Buy · 🎯$34
Price at call : $16.53 — upside +106%
Today : $23.52 — upside +45%
Expected +106% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 100% (1 call matured) · 📊 on Health : 64.7% · +17.5% (51 calls)
+42.9%
stock +43% · XLV +20%
matured Nov 7, 24
RBC Capital ↗
Nov 8, 23
▲ Outperform · 🎯$32
Price at call : $16.53 — upside +94%
Today : $23.52 — upside +36%
Expected +94% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 33% (6 calls matureds) · 📊 on Health : 31.1% · -10.5% (167 calls)
+42.9%
stock +43% · XLV +20%
matured Nov 7, 24
▲ Outperform · 🎯$36
Price at call : $17.24 — upside +109%
Today : $23.52 — upside +53%
Expected +109% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on XNCR : 50% (8 calls matureds) · 📊 on Health : 37% · +6.7% (54 calls)
+34.4%
stock +34% · XLV +16%
matured Nov 7, 24
B of A Securities ↗
May 19, 23
▲ Buy · 🎯$42
Price at call : $27.45 — upside +53%
Today : $23.52 — upside +79%
Expected +53% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 0% (1 call matured) · 📊 on Health : 51.9% · +3.9% (156 calls)
-13.5%
stock -13% · XLV +11%
matured May 18, 24
▲ Outperform · 🎯$37
Price at call : $26.83 — upside +38%
Today : $23.52 — upside +57%
Expected +38% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 50% (8 calls matureds) · 📊 on Health : 37% · +6.7% (54 calls)
-11.8%
stock -12% · XLV +7%
matured May 8, 24
▲ Outperform · 🎯$44
Price at call : $37.59 — upside +17%
Today : $23.52 — upside +87%
Expected +17% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on XNCR : 50% (8 calls matureds) · 📊 on Health : 37% · +6.7% (54 calls)
+10.2%
stock +10% · XLV +10%
matured Dec 7, 19
Frequently asked questions
Should I buy Xencor Inc stock?
This isn't buy advice. For Xencor Inc, the analyst consensus is "Buy", with an average price target of $29.50 (+25% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Xencor Inc). We show the numbers — you decide.
Is it too late to buy Xencor Inc? How high can it go?
The most bullish analyst target on Xencor Inc is $46.00 (+96% above today's price); the average is $29.50. That's the upside they see. Check how reliable those analysts have actually been on Xencor Inc on our site before trusting it.
Is Xencor Inc still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 16 analysts have a real record on Xencor Inc, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Xencor Inc? The case for and against
The arguments for and against, one by one, from the numbers: why invest in XNCR (and why hesitate).
What has Xencor Inc's past performance been?
Historical returns and a "how much if I had invested" calculator: XNCR performance & returns.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX